Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:1516-1523

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waltenberger, J.
Right arrow Articles by Funa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waltenberger, J.
Right arrow Articles by Funa, K.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:1516-1523.)
© 1996 American Heart Association, Inc.


Articles

Ischemia-Induced Transplant Arteriosclerosis in the Rat

Induction of Peptide Growth Factor Expression

Johannes Waltenberger; M. Levent Akyurek; Magnus Aurivillius; Alkwin Wanders; Erik Larsson; Bengt Fellstrom; Keiko Funa

the Department of Internal Medicine II (J.W.), Ulm University Medical Center, Germany; Ludwig Institute for Cancer Research (J.W., M.A., K.F.), Biomedical Center, Uppsala, Sweden; and Department of Pathology (M.L.A., E.L.) and Department of Internal Medicine (A.W., B.F.), Uppsala University, Sweden.

Correspondence to Keiko Funa, Ludwig Institute for Cancer Research, Biomedical Center, S-751 24 Uppsala, Sweden. E-mail Keiko.Funa@LICR.uu.se.

Peptide growth factors have been reported to contribute to the atherogenic process, and they are known to mediate signals for vascular remodeling. Using syngeneic and allogeneic rat aorta transplant models, we analyzed the impact of cold ischemia time up to 24 hours and reperfusion injury on development of transplant arteriosclerosis during the first 2 months after transplantation. The expression of the transforming growth factor-ß (TGF-ß) family as well as the platelet-derived growth factor (PDGF) and its receptors was studied by use of immunohistochemistry, followed by semiquantitative evaluation and multivariate analysis. In the syngeneically transplanted aortas, the expression of TGF-ß1, PDGF, and the two PDGF receptors in the neointima increased significantly with the extent of cold ischemia time. Furthermore, there was a significant induction of the latent TGF-ß binding protein in the neointima as well as TGF-ß2 in the media, both correlating with the observation time after transplantation. In the allogeneic grafts, all examined proteins were already induced strongly 2 weeks after transplantation, even at the shortest ischemic period studied (1 hour). However, no positive correlation between growth factor expression and cold ischemia or observation time could be found. Double immunohistochemistry revealed that macrophages express PDGF and its receptors as well as TGF-ß1. Smooth muscle cells express both types of PDGF receptors, and a few T cells express TGF-ß1 as well as PDGF receptors. In summary, TGF-ß and PDGF are induced by allogeneic as well as ischemic stimuli in transplanted aortas, suggesting a role in the pathogenesis of transplant arteriosclerosis and representing a potential target for therapeutic intervention.


Key Words: arteriosclerosis • transplantation • ischemia • growth factors • neointima




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
B. Reinhardt, T. Mertens, U. Mayr-Beyrle, H. Frank, A. Luske, K. Schierling, and J. Waltenberger
HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF {beta}-receptor
Cardiovasc Res, July 1, 2005; 67(1): 151 - 160.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Yang, K. Sato, T. Aprahamian, N. J. Brown, J. Hutcheson, A. Bialik, H. Perlman, and K. Walsh
Endothelial Overexpression of Fas Ligand Decreases Atherosclerosis in Apolipoprotein E-Deficient Mice
Arterioscler Thromb Vasc Biol, August 1, 2004; 24(8): 1466 - 1473.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Kanzaki and M. Otabe
Latent Transforming Growth Factor-{beta} Binding Protein-1, a Component of Latent Transforming Growth Factor-{beta} Complex, Accelerates the Migration of Aortic Smooth Muscle Cells in Diabetic Rats Through Integrin-{beta}3
Diabetes, March 1, 2003; 52(3): 824 - 828.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Sata, Z. Luo, and K. Walsh
Fas Ligand Overexpression on Allograft Endothelium Inhibits Inflammatory Cell Infiltration and Transplant-Associated Intimal Hyperplasia
J. Immunol., June 1, 2001; 166(11): 6964 - 6971.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Waltenberger, A. Uecker, J. Kroll, H. Frank, U. Mayr, J. D. Bjorge, D. Fujita, A. Gazit, V. Hombach, A. Levitzki, et al.
A Dual Inhibitor of Platelet-Derived Growth Factor {beta}-Receptor and Src Kinase Activity Potently Interferes With Motogenic and Mitogenic Responses to PDGF in Vascular Smooth Muscle Cells : A Novel Candidate for Prevention of Vascular Remodeling
Circ. Res., July 9, 1999; 85(1): 12 - 22.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Chen, L. M. Akyurek, B. Fellstrom, P. Hayry, and L. C. Paul
Eotaxin and Capping Protein in Experimental Vasculopathy
Am. J. Pathol., July 1, 1998; 153(1): 81 - 90.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Waltenberger
Modulation of Growth Factor Action : Implications for the Treatment of Cardiovascular Diseases
Circulation, December 2, 1997; 96(11): 4083 - 4094.
[Abstract] [Full Text]